The immunology of btb: a multi-host multi-parasite perspective

Similar documents
TB vaccine progress. Hassan Mahomed. Institute of Infectious Disease and Molecular Medicine, School of Child and Adolescent Health,

BCG: Past, Present and Future. Nwora Lance Okeke, MD, MPH August 24, 2016

TB, BCG and other things. Chris Conlon Infectious Diseases Oxford

TB PREVENTION: TREATMENT OF LATENT TB INFECTION AND BCG VACCINATION

Innate Immunity. Chapter 3. Connection Between Innate and Adaptive Immunity. Know Differences and Provide Examples. Antimicrobial peptide psoriasin

Acquired Immunity Cells are initially and require before they can work Responds to individual microbes

Partnering to Support Research Capacity in TB Endemic Countries

Shigella Pathogenesis and Vaccine Development

Perspective in novel TB vaccine development Mohamed Ridha BARBOUCHE M.D., Ph.D. Department of Immunology Institut Pasteur de Tunis

Immunology of TB and its relevance to TB Control

#4 (Tuberculosis OR TB OR Pulmonary Tuberculosis OR Multi-Drug Resistant Tuberculosis OR MDR OR Extremely-Drug Resistant Tuberculosis or XDR)

Medical Bacteriology- lecture 13. Mycobacterium Actinomycetes

The Adaptive Immune Response. B-cells

Immunology. T-Lymphocytes. 16. Oktober 2014, Ruhr-Universität Bochum Karin Peters,

Research Article Cytokines as Biomarkers in the Diagnosis of MDR TB Cases

Tuberculosis Now! Jon S Friedland MA, FRCPE, FMedSci. Infectious Diseases & Immunity

Advanced Lecture on One Health

How Is TB Transmitted? Sébastien Gagneux, PhD 20 th March, 2008

Time course of immune response

Innate Immunity. Connection Between Innate and Adaptive Immunity. Know Differences and Provide Examples Chapter 3. Antimicrobial peptide psoriasin

Host-Pathogen Interactions in Tuberculosis

February Emerging Infectious Diseases: The Global Picture

Medical Bacteriology- Lecture 10. Mycobacterium. Actinomycetes. Nocardia

Global progress in vaccine development

Bovine TB: the science-policy challenges

Summary of Key Points WHO Position Paper on BCG Vaccine, February 2018

MODULE ONE" TB Basic Science" Treatment Action Group TB/HIV Advocacy Toolkit

5. Over the last ten years, the proportion of HIV-infected persons who are women has: a. Increased b. Decreased c. Remained about the same 1

Immune response to infection

Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION

Childhood TB (and the mother-child dyad)

Early Therapeutic Vaccine Clinical Trial Development

Ongoing Research on LTBI and Research priorities in India

General Overview of Immunology. Kimberly S. Schluns, Ph.D. Associate Professor Department of Immunology UT MD Anderson Cancer Center

Structure and Function of Antigen Recognition Molecules

VMC-221: Veterinary Immunology and Serology (1+1) Question Bank

Characteristics of Mycobacterium

Cell Mediated Immunity CELL MEDIATED IMMUNITY. Basic Elements of Cell Mediated Immunity (CMI) Antibody-dependent cell-mediated cytotoxicity (ADCC)

V. Chevalier. UR AGIRs «Animal et Gestion Intégrée des Risques» CIRAD ES

Immunological Aspects of Parasitic Diseases in Immunocompromised Individuals. Taniawati Supali. Department of Parasitology

10th International Rotavirus Symposium Bangkok, Thailand

THE GLOBAL HEALTH SECURITY AGENDA. We have to change our mindsets and start thinking about biological threats as the security threats that they are.

National Health & Medical Research Council (NHMRC) Results Fellowships and Australia/European Union Collaborative Grants Scheme 2018

Evolving Realities of HIV Treatment in Resource-limited Settings

Introduction to Immunopathology

The Burden of TB in the Population under the Partnership in Health Project

7/6/2009. The study of the immune system and of diseases that occur as a result of inappropriate or inadequate actions of the immune system.

IS VITAMIN D IMPORTANT IN THE MANAGEMENT OF TUBERCULOSIS?

Innate immune regulation of T-helper (Th) cell homeostasis in the intestine

Chapter 10 (pages ): Differentiation and Functions of CD4+ Effector T Cells Prepared by Kristen Dazy, MD, Scripps Clinic Medical Group

Immune response to pathogens

Sponsored document from Microbes and Infection / Institut Pasteur

Bovine TB testing strategy: optimising the use of current diagnostic tools

Monitoring tuberculosis progression using MRI and stereology

What can pathogen phylogenetics tell us about cross-species transmission?

生命科学基础 (21)- 动物的免疫器官. The Immune System. KE, Yuehai 柯越海. Zhejiang University, School of Basic Medical Sciences (BMS-ZJU) 浙江大学基础医学院

Newly Recognized Components of the Innate Immune System

Pathogens and the immune system

Unit 9 New life College faculty: Ramesh Kumar Subject: Life Sciences date: 15jan 2016

Immunity and Infection. Chapter 17

Anti-infectious Immunity

Felix Yarovinsky. Department of Immunology, UT Southwestern Medical Center. Innate immune defense to Toxoplasma gondii

MYCOBACTERIA. Pulmonary T.B. (infect bird)

Understanding basic immunology. Dr Mary Nowlan

anys. Reinfection vs. Reactivation Is this the question?

CELL BIOLOGY - CLUTCH CH THE IMMUNE SYSTEM.

4b. Innate (nonspecific) Immunity

El futuro del diagnostico de la ITL. en tiempos de crisis. Professor Ajit Lalvani FMedSci Chair of Infectious Diseases

The Case of the Spring Break Consequences

ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT

Innate Immunity. Jan 8 th Prof. dr. sc. Ivana Novak Nakir 1

New Horizons for Neglected Diseases

Regulation of Immunopathology in Mycobacterium tuberculosis infection. Hillarie Plessner Windish. Bachelor of Arts, Arcadia University, 2003

All animals have innate immunity, a defense active immediately upon infection Vertebrates also have adaptive immunity

Shelley Rhodes & Martin Vordermeier

Campbell's Biology: Concepts and Connections, 7e (Reece et al.) Chapter 24 The Immune System Multiple-Choice Questions

Introduction. In the past 15 years, several technological advancements have open new perspectives and applications in the field of vaccinology.

Innate immunity. Abul K. Abbas University of California San Francisco. FOCiS

2 - Adaptive Immunity

Adaptive Immunity to Bacteria. T cell subsets

ANTIBODIES DETERMINE VIRULENCE IN DENGUE. Scott B HALSTEAD, M.D. DIRECTOR, Research Pediatric Dengue Vaccine Initiative IVI, Seoul, Korea

Animal Models to Understand Immunity

227 28, 2010 MIDTERM EXAMINATION KEY

La risposta immune all infezione da virus ebola. Chiara Agrati, PhD

IN VIVO STUDIES ON VIRAL VIRULENCE

HLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol

Better Training for Safer Food BTSF

Sanofi updates information on dengue vaccine. 29 November 2017 (Sanofi Press Release)

Change In Population TB Incidence Trends After The Roll-Out Of ART in Karonga District, North Malawi:

Overview of the immune system

Anastasios E. Germenis

A Multicistronic DNA Vaccine Induces Significant Protection against Tuberculosis in Mice and Offers Flexibility in the Expressed Antigen Repertoire.

Innate vs Adaptive Response

WHAT CAN BE LEARNED FROM VETERINARY VACCINES; THE DIVA CONCEPT

Indonesia s challenges and needs in improving national capabilities for disease surveillance, detection and diagnosis and public health systems:

REGULATION OF GRANULOMA FORMATION IN MURINE MODELS OF TUBERCULOSIS. Holly Marie Scott. Bachelors of Science, Mount Union College, 1998

Microbiological Societies (IUMS) Congress This conference took place in Montreal, CANADA during

MODULE 5. Dengue. Edwin J. Asturias Associate Professor of Pediatrics Senior Investigator Director for Latin America

Advances in Cancer Immunotherapy

RUTI: a new therapeutic vaccine to shorten the latent tuberculosis infection treatment

Transcription:

The immunology of btb: a multi-host multi-parasite perspective Simon Babayan Institute of Biodiversity, Animal Health & Comparative Medicine simon.babayan@glasgow.ac.uk @SimonAB

Immuno-epidemiology of infectious diseases Primary interest: host-parasite interactions at the level of the organism, and the effects of natural variation on the host's immune defences Foremost interface of this interaction is the immune response Biotic environmental factors: exposure via air, water, soil, vectors, & animal reservoirs; population density; nutritional resource availability... At the individual level: Physiological factors: age, sex, nutritional status, past and current infections Immunity: resistance/susceptibility, tolerance/virulence, health... At the Population: disease transmission, demographic structure & density

Wild Immunology Wild Immunology: how the immune system functions given natural variation in coinfection history, variable nutritional resources, etc. emphasis on immune mechanisms, with a view to inform intervention strategies (see Pedersen & Babayan 2011) No lab experiment can satisfactorily simulate the interplay of an individual with its natural environment However, knowledge derived from past and concurrent lab immunology is crucial to disentangling causes & effects of such variation

Crosstalk between lab & wild Molecules, cells, organisms omics Organisms, populations, ecosystems In the lab: controlled environmental and genetic variation allows the study of mechanisms that drive immunity. In the wild: how natural variation affects the expression of immunity from individual organism to population levels.

Old methods and new opportunities Swelling in response to immunogenic inoculations: how to interpret these, e.g. sheep red blood cells or KLH? Serology: antibodies available for many species, but is it always a good enough predictor of protection? Detection limits? Active or past infection? Exposure or protection? PCR & co: requires knowledge of genome very small fraction of target species have been sequenced More recently, omics, and specifically de novo transcriptomes + digital transcriptomics is often a necessary first step. Challenging in its own way (e.g. Curse of dimensionality), but it also opens up unprecedented insights into the study system

Basic requirements to study the relevant species Demographics: age, sex, reproductive status, weight, fat scores, etc. Diagnostics: pathogen presence and burdens Immunology: for non-model organisms, a combination of classical immune measures (differential leukocyte counts, bacterial killing essays, etc) and, increasingly, 'omics Computational biology: bioinformatics + scalable data analysis

Resources for studying M. bovis from a multi-host-pathogen angle Mycobacterium spp. genome: see Stephen Gordon s talk next! Bovine genome (Bos taurus): available, relatively mature, e.g. bovinegenome.org; bovine gene arrays from Affymetrix, etc. Bovine immune system relatively well studied, many reagents available Multiple host ( reservoir ) species: badgers, fallow deer, but unlikely to have published genomes nor specific immunological reagents. => de novo assembly, reagent development

Protective immunity to Mycobacterium Journal of Immunology Research Sia et al. 2015 Th1: IFN-γ producing CD4+ T cells (necessary but not sufficient for protection) T cells Dendritic cell Recruitment IFN-γ Neutrophil IFN-γ receptor Neutrophil recruitment via IL-8 + IL-12 CCL22, MIP-1α CREB STAT-1 binding protein MR LAM PPARγ Cyclooxygenase 2 IL-8 TLR + + LM LAM ManLAM PIM Hsp60/65 NOS2 NOS3 NFκB M. tuberculosis MHC class II Downregulated MHC class II expression LL-37 + CD91 1,25(OH) 2 D ManLAM PIM MBL Calreticulin Phagosome Restricted replication Figure 1: Human alveolar macrophages possess an array of receptors to recognize M. tuberculosis (Mtb). In response to Mtb infection κ γ γ γδ T cells: up to 70% PBMC in ruminants (5-10% in mice & humans; badgers?). Functionally diverse, innate/adaptive, antibacterial, anti-lipid responses. IL-17: early production by γδ T cells improves protective memory cells; late IL-17 (Th17) correlates with reduced lesions (though not necessary for protection)

Published August 8, 2011 ARTICLE Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway Julius A. Potian, 1,2 Wasiulla Rafi, 1,2 Kamlesh Bhatt, 1,2 Amanda McBride, 1,2 William, C. Gause, 1,3 and Padmini Salgame 1,2 1 Department of Medicine, 2 Center for Emerging Pathogens, and 3 Center for Immunity and Inflammation, University of Medicine and Dentistry of New Jersey, Newark, NJ 07101 Received 18 Jan 2012 Accepted 11 Apr 2012 Published 22 May 2012 Infect Immun, 2015, 83:2118 2126. DOI: 10.1038/ncomms1840 Fasciola hepatica is associated with the failure to detect bovine tuberculosis in dairy cattle Jen Claridge 1, Peter Diggle 1,2, Catherine M. McCann 1,, Grace Mulcahy 3, Rob Flynn 3,, Jim McNair 4, Sam Strain 4, Michael Welsh 4, Matthew Baylis 1, * & Diana J.L. Williams 1, * Protein Energy Malnutrition during Vaccination Has Limited Influence on Vaccine Efficacy but Abolishes Immunity if Administered during Mycobacterium tuberculosis Infection Fine PE (1995) Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346: 1339-1345. STUDY Lat U/R Type OR and 99% CI VE NORWAY, gen popn[42] 65 U+R COH 81% SWEDEN, gert popn[43] 62 U+R COH 80% SWEDEN, military[44] 62 U+R COH 55% DENMARK, school[45] 56 U O/B 94% IRELAND, school[46] 55 R O/B 82% CANADA Indians[47][*] 55 R T 81% CANADA ALBERTA Indians[48][*] 55 R C.C 57% CANADA MANITOBA Indians[49][*] 55 R C.C 70% UK, schoolchildren[50][*] 53 U+R T 77% UK, gen popn 1973[51] 53 U+R COH 79% UK, gert popn 1978[52] 53 U+R COH 74% UK, gen popn 1983[7] 53 U+R COH 75% UK, Asians[53][*] 53 U C.C 49% UK, BIRMINGHAM Asians[54][*] 52 U C.C 64% UK, BIRMINGHAM[55] 52 U COH 88% USA, indians[25][*] 52 R T 79% USA, CHICAGO infants[56][*] 42 U T 72% USA, NEW YORK infants[57] 41 U T 7%a KOREA, SEOUL[58] 38 U H/H 74% ARGENTINA, BUENOS AIRES[59][*] 35 U C.C 73% USA, GEORGIA school[26][*] 33 U+R T -56%a USA, GEORGIA ALABAMA gen popn[60][*] 33 U+R T 16% ISRAEL, children[61] 31 U+R COH 38% SOUTH AFRICA, miners[62][*] 27 U+R T 62% AUSTRALIA, QUEENSLAND[63][*] 20 U+R C.C 41% PUERTO RICO[15][*] 18 R+U T 29% HAITI[64][*] 18 R+U T 80% BURMA, RANGOON[65][*] 17 U C.C 38% THAILAND, BANGKOK[66] 14 U C.C 74% THAILAND, BANGKOK[67] 14 U C.C 83% THAILAND, BANGKOK[68] 14 U H/H 47% INDIA, MADANAPALLE[27][*] 13 R T 20% INDIA, CHINGLEPUT[101][*] 13 R T -19% PAPUA NEW GUINEA[69] 10 U+R C.C 41% MALAWI, KARONGA[8] 10 R COH -11% INDONESIA, JAKARTA[70][*] 6 U C.C 37% TOGO LOME[71] 6 U H/H 66% COLUMBIA, CALl[72][*] 4 U C.C 16% CAMEROUN, YAOUNDE[73] 4 U C.C 66% KENYA, KISUMU[17] 0 R C.C 22% Truc Hoang, a Else Marie Agger, a Joseph P. Cassidy, b Jan P. Christensen, c Peter Andersen a Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark a ; Veterinary Sciences Centre, School of Veterinary Medicine, University College Dublin, Belfield, Dublin, Ireland b ; International Health, Immunology and Microbiology, The Panum Institute, Copenhagen, Denmark c

'Short' list of predictors of anti-tb protective immunity? Pre-existing infections that might degrade or prevent anti-m.b. immunity Nutritional status: trade-offs between competing physiological demands e.g. growth, pregnancy T cell phenotypes (Th1, Th2, Th17), inflammatory markers, chemokines Age: parental effects in the young, immunosenescence in the old

Beyond observational data: experimental manipulation Selective parasite removal: insecticides, anthelminthics, antibiotics, vaccines Nutrition: food availability, distribution, and quality Inter-individual contacts: barriers, feeders, water spots Sampling: longitudinal + cross-sectional; noninvasive + destructive

Exciting prospects Immune system as a black box is largely behind us We are getting better at studying non-model organisms Omics: cheaper and getting more powerful (come to Graham Hamilton s talk tomorrow!) Data analysis: biology is starting to benefit from the staggering progress in computer science